Jianbang Chiang

By request Our 2 hour ASH abstract session @AaronGoodman33 @ManniMD1 and me and many others We get to the abstracts around 35 mins in So many good ones, including CAR PRISM and AQUILA #ASH24

When I see something like this, where the title says one thing and the data something completely different, I’m reminded of Michael Corleone saying: 'This insults my intelligence... and makes me very angry 😡” #ash2024 #lymphoma

#fanboy moment to hear from @VPrasadMDMPH and @AaronGoodman33 discuss what is wrong with oncology trials these days. Especially love their humor and wit.

🥂 to @PoonEileen and the rest of the AYA team for the successful opening of #AYASeminar24! Thanks for the invite to speak on equity in AYA Cancer Care in Asia. #importantconversations #AYAO. Thank you to @herbloong, Dr Kayo Nakata and Dr Kim Hee Jeong for coming to #NCCS today.

The first step to population health is to frame the problem. Our study showed that cascade testing for hereditary cancer syndromes often suffer from lack of implementation science approaches, resulting in reduced impact. nature.com/articles/s4152…

Very grateful to have the opportunity to share our work on using Deauville Scoring in DLBCL patients at the upcoming ASH 2023 Conference :) Many thanks to partner in crime @ChenEe1999 and @JB_Chiang for the guidance :) Thankful for the #ASH23 achievement award funding too!

Fresh out of the oven - the AITL-PI score! Clinical features and prognostic outcomes of angioimmunoblastic T cell lymphoma in an Asian multicenter study tandfonline.com/doi/full/10.10… #lymphoma

Congrats to the CGS team for a highly engaging and educational session on germline genetics at the iBRCA forum in Singapore.

I was watching Lord of the Rings last night and realized there are many parallels with academia! A thread 🧵👇

Join us @ our 1st Sarcoma & Skin Symposium & Workshop, recommended by @ESSOnews @ctosociety! With a stellar international faculty, we cover best global management practices & research updates in #Sarcoma & #SkinMalignancy. #sarcomaskin2023 🗓️17-20 Jul 23 ℹ️sarcomaskin.org

SGH lit up in blue and green (the official colors of NF) to raise awareness for a genetic disease that needs attention, end social stigma, and perhaps find a cure. #endnf

Here is an excellent overview of scientific paper writing. You can quickly review the structuring guide for each section before attempting to write it. Source: journals.plos.org/ploscompbiol/a…

Loved this provocative slide by @DrTonyLetai @DanaFarber @harvardmed in his lecture today: #cancer chemotherapy vs targeted drug therapy

Med onco debate. Will NGS improve cancer patients' outcome? #medonco #nccs #ncis #ttsh

Huge congrats to CEx2 on their poster evaluating the role of consolidation RT using PET-CT at the #Singapore #lymphoma scientific symposium. Med students today, doctors tomorrow, but improving patient care always.

I did not expect this piece to resonate with so many people. This is dedicated to all the clinicians in the trenches. thelancet.com/journals/lanha…

At the inaugural CRTI-APAC in Hanoi. Beautiful venue and absolutely stuffed (with knowledge and food) #ASH #ashcrti

Not groundbreaking in the big scheme of things, but super pleased that our special issue in our beloved Singapore Medical Journal on our beloved topic #Genetics #Genomics now out journals.lww.com/smj/toc/2023/0… @jonathanlwj @NUSMedicine @NUSResearch @loong_shaun

Help advance the care of Adolescents and Young Adults Oncology! Join us in our ✨1st ✨AYAO Symposium in Singapore featuring key opinion leaders from Australia, HongKong, Singapore and Netherlands! Sign up and join us in this community!! @OncoAlert #ayao #oncology

Submit an abstract for #SLSS2023 18th March 2023! Registration is free! tinyurl.com/SLSS2023